Last 12 months
Inside the activity.
0 purchase rows · 21 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2024 Filed Jun 5, 2024 22:32 UTC |
GOEBEL DAVIDDirector
|
GrantDividend Equivalent Units · Derivative | 0.788 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017974 · form4.xml · derivative · entry 1 GOEBEL DAVID · CIK 0001137523 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.533 Underlying: Common Stock · 0.788 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:04 UTC |
DEMING CLAIBORNE PDirector
|
GrantDividend Equivalent Units · Derivative | 0.071 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017992 · form4.xml · derivative · entry 4 DEMING CLAIBORNE P · CIK 0001166951 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.965 Underlying: Common Stock · 0.071 shares Expires not disclosed F6 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F4 · balance_after: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F6 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:04 UTC |
DEMING CLAIBORNE PDirector
|
GrantDividend Equivalent Units · Derivative | 0.441 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017992 · form4.xml · derivative · entry 3 DEMING CLAIBORNE P · CIK 0001166951 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.894 Underlying: Common Stock · 0.441 shares Expires not disclosed F6 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F7 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F6 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F7 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:04 UTC |
DEMING CLAIBORNE PDirector
|
GrantDividend Equivalent Units · Derivative | 0.381 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017992 · form4.xml · derivative · entry 2 DEMING CLAIBORNE P · CIK 0001166951 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.774 Underlying: Common Stock · 0.381 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:04 UTC |
DEMING CLAIBORNE PDirector
|
GrantDividend Equivalent Units · Derivative | 0.788 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017992 · form4.xml · derivative · entry 1 DEMING CLAIBORNE P · CIK 0001166951 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.533 Underlying: Common Stock · 0.788 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:24 UTC |
MILLER DAVID BDirector
|
GrantDividend Equivalent Units · Derivative | 0.059 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017999 · form4.xml · derivative · entry 4 MILLER DAVID B · CIK 0001167138 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.953 Underlying: Common Stock · 0.059 shares Expires not disclosed F6 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F7 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F6 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F7 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:24 UTC |
MILLER DAVID BDirector
|
GrantDividend Equivalent Units · Derivative | 0.441 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017999 · form4.xml · derivative · entry 3 MILLER DAVID B · CIK 0001167138 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.894 Underlying: Common Stock · 0.441 shares Expires not disclosed F6 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F7 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F7 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:24 UTC |
MILLER DAVID BDirector
|
GrantDividend Equivalent Units · Derivative | 0.319 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017999 · form4.xml · derivative · entry 2 MILLER DAVID B · CIK 0001167138 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.647 Underlying: Common Stock · 0.319 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:24 UTC |
MILLER DAVID BDirector
|
GrantDividend Equivalent Units · Derivative | 0.788 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017999 · form4.xml · derivative · entry 1 MILLER DAVID B · CIK 0001167138 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.533 Underlying: Common Stock · 0.788 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:05 UTC |
Jeff Charles GalagherEVP, Chief Financial Officer
|
GrantDividend Equivalent Units · Derivative | 0.545 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017908 · form4.xml · derivative · entry 1 Jeff Charles Galagher · CIK 0002014914 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.545 Underlying: Common Stock · 0.545 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on March 7, 2024. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on March 7, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:06 UTC |
Segal BlakeSVP, QuickChek
|
GrantDividend Equivalent Units · Derivative | 0.446 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017909 · form4.xml · derivative · entry 4 Segal Blake · CIK 0001882861 · SVP, QuickChek 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.905 Underlying: Common Stock · 0.446 shares Expires not disclosed F6 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F7 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F7 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. F6 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:06 UTC |
Segal BlakeSVP, QuickChek
|
GrantDividend Equivalent Units · Derivative | 0.548 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017909 · form4.xml · derivative · entry 3 Segal Blake · CIK 0001882861 · SVP, QuickChek 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.891 Underlying: Common Stock · 0.548 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F5 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:06 UTC |
Segal BlakeSVP, QuickChek
|
GrantDividend Equivalent Units · Derivative | 0.702 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017909 · form4.xml · derivative · entry 2 Segal Blake · CIK 0001882861 · SVP, QuickChek 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.491 Underlying: Common Stock · 0.702 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:06 UTC |
Segal BlakeSVP, QuickChek
|
GrantDividend Equivalent Units · Derivative | 0.251 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017909 · form4.xml · derivative · entry 1 Segal Blake · CIK 0001882861 · SVP, QuickChek 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.446 Underlying: Common Stock · 0.251 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on September 13, 2021. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on September 13, 2021. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 22:33 UTC |
Turner RosemaryDirector
|
GrantDividend Equivalent Units · Derivative | 0.441 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017976 · form4.xml · derivative · entry 3 Turner Rosemary · CIK 0001863747 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.894 Underlying: Common Stock · 0.441 shares Expires not disclosed F6 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F7 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F6 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F7 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 22:33 UTC |
Turner RosemaryDirector
|
GrantDividend Equivalent Units · Derivative | 0.605 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017976 · form4.xml · derivative · entry 2 Turner Rosemary · CIK 0001863747 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.294 Underlying: Common Stock · 0.605 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 22:33 UTC |
Turner RosemaryDirector
|
GrantDividend Equivalent Units · Derivative | 0.788 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017976 · form4.xml · derivative · entry 1 Turner Rosemary · CIK 0001863747 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.533 Underlying: Common Stock · 0.788 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:03 UTC |
CHUMLEY ROBERT JSVP, Chief Digital Officer
|
GrantDividend Equivalent Units · Derivative | 0.446 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017905 · form4.xml · derivative · entry 3 CHUMLEY ROBERT J · CIK 0001684248 · SVP, Chief Digital Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.905 Underlying: Common Stock · 0.446 shares Expires not disclosed F5 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:03 UTC |
CHUMLEY ROBERT JSVP, Chief Digital Officer
|
GrantDividend Equivalent Units · Derivative | 0.548 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017905 · form4.xml · derivative · entry 2 CHUMLEY ROBERT J · CIK 0001684248 · SVP, Chief Digital Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.891 Underlying: Common Stock · 0.548 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSU. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSU. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:03 UTC |
CHUMLEY ROBERT JSVP, Chief Digital Officer
|
GrantDividend Equivalent Units · Derivative | 0.752 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017905 · form4.xml · derivative · entry 1 CHUMLEY ROBERT J · CIK 0001684248 · SVP, Chief Digital Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.096 Underlying: Common Stock · 0.752 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSU. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSU. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:10 UTC |
Keyes James WDirector
|
GrantDividend Equivalent Units · Derivative | 0.441 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017912 · form4.xml · derivative · entry 2 KEYES JAMES W · CIK 0001235367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.894 Underlying: Common Stock · 0.441 shares Expires not disclosed F4 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F5 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:10 UTC |
Keyes James WDirector
|
GrantDividend Equivalent Units · Derivative | 0.788 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017912 · form4.xml · derivative · entry 1 KEYES JAMES W · CIK 0001235367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.533 Underlying: Common Stock · 0.788 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:11 UTC |
MURPHY ROBERT MADISONDirector
|
GrantDividend Equivalent Units · Derivative | 0.441 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017914 · form4.xml · derivative · entry 2 MURPHY ROBERT MADISON · CIK 0001216894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.894 Underlying: Common Stock · 0.441 shares Expires not disclosed F4 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F5 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:11 UTC |
MURPHY ROBERT MADISONDirector
|
GrantDividend Equivalent Units · Derivative | 0.788 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017914 · form4.xml · derivative · entry 1 MURPHY ROBERT MADISON · CIK 0001216894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.533 Underlying: Common Stock · 0.788 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:08 UTC |
West Malynda KEVP & Chief Operating Officer
|
GrantDividend Equivalent Units · Derivative | 1.389 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017911 · form4.xml · derivative · entry 3 West Malynda K · CIK 0001381734 · EVP & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.817 Underlying: Common Stock · 1.389 shares Expires not disclosed F5 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:08 UTC |
West Malynda KEVP & Chief Operating Officer
|
GrantDividend Equivalent Units · Derivative | 1.246 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017911 · form4.xml · derivative · entry 2 West Malynda K · CIK 0001381734 · EVP & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.844 Underlying: Common Stock · 1.246 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:08 UTC |
West Malynda KEVP & Chief Operating Officer
|
GrantDividend Equivalent Units · Derivative | 1.553 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017911 · form4.xml · derivative · entry 1 West Malynda K · CIK 0001381734 · EVP & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18.797 Underlying: Common Stock · 1.553 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:05 UTC |
Taylor Jack TDirector
|
GrantDividend Equivalent Units · Derivative | 0.074 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017995 · form4.xml · derivative · entry 4 Taylor Jack T · CIK 0001570352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.366 Underlying: Common Stock · 0.074 shares Expires not disclosed F6 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F7 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F4 · balance_after: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F7 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:05 UTC |
Taylor Jack TDirector
|
GrantDividend Equivalent Units · Derivative | 0.441 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017995 · form4.xml · derivative · entry 3 Taylor Jack T · CIK 0001570352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.292 Underlying: Common Stock · 0.441 shares Expires not disclosed F6 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F4 · balance_after: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F7 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:05 UTC |
Taylor Jack TDirector
|
GrantDividend Equivalent Units · Derivative | 0.398 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017995 · form4.xml · derivative · entry 2 Taylor Jack T · CIK 0001570352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.851 Underlying: Common Stock · 0.398 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:05 UTC |
Taylor Jack TDirector
|
GrantDividend Equivalent Units · Derivative | 0.788 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017995 · form4.xml · derivative · entry 1 Taylor Jack T · CIK 0001570352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.533 Underlying: Common Stock · 0.788 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:06 UTC |
Phillips Jeanne LinderDirector
|
GrantDividend Equivalent Units · Derivative | 0.441 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017996 · form4.xml · derivative · entry 4 Phillips Jeanne Linder · CIK 0001759743 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.894 Underlying: Common Stock · 0.441 shares Expires not disclosed F7 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F8 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F7 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F8 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:06 UTC |
Phillips Jeanne LinderDirector
|
GrantDividend Equivalent Units · Derivative | 0.319 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017996 · form4.xml · derivative · entry 3 Phillips Jeanne Linder · CIK 0001759743 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.554 Underlying: Common Stock · 0.319 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on fully vested RSUs issued to the Reporting Person on in lieu of quarterly cash retainer(s) payable under the issuer's compensation policy. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:06 UTC |
Phillips Jeanne LinderDirector
|
GrantDividend Equivalent Units · Derivative | 0.605 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017996 · form4.xml · derivative · entry 2 Phillips Jeanne Linder · CIK 0001759743 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.159 Underlying: Common Stock · 0.605 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.exercise_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · derivative.expiration_date: The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units in accordance with their deferral election form to the reporting person's termination of service form the Board. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:06 UTC |
Phillips Jeanne LinderDirector
|
GrantDividend Equivalent Units · Derivative | 0.788 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017996 · form4.xml · derivative · entry 1 Phillips Jeanne Linder · CIK 0001759743 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.533 Underlying: Common Stock · 0.788 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:10 UTC |
Landen Diane NDirector
|
GrantDividend Equivalent Units · Derivative | 0.441 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017913 · form4.xml · derivative · entry 2 Landen Diane N · CIK 0001583746 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.894 Underlying: Common Stock · 0.441 shares Expires not disclosed F4 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F5 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:10 UTC |
Landen Diane NDirector
|
GrantDividend Equivalent Units · Derivative | 0.788 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017913 · form4.xml · derivative · entry 1 Landen Diane N · CIK 0001583746 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.533 Underlying: Common Stock · 0.788 shares Expires not disclosed F1 · security: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. F2 · price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects the accrual of dividend equivalent units on outstanding restricted stock units ("RSUs") granted to the Reporting Person under the 2013 Stock Plan for Non-employee Directors. Each dividend equivalent unit reflects the right to receive one share of common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 10, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:06 UTC |
Smith Donald R JrVP, CAO & Treasurer
|
GrantDividend Equivalent Units · Derivative | 0.248 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017910 · form4.xml · derivative · entry 3 Smith Donald R Jr · CIK 0001583749 · VP, CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.503 Underlying: Common Stock · 0.248 shares Expires not disclosed F5 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:06 UTC |
Smith Donald R JrVP, CAO & Treasurer
|
GrantDividend Equivalent Units · Derivative | 0.299 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017910 · form4.xml · derivative · entry 2 Smith Donald R Jr · CIK 0001583749 · VP, CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.123 Underlying: Common Stock · 0.299 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:06 UTC |
Smith Donald R JrVP, CAO & Treasurer
|
GrantDividend Equivalent Units · Derivative | 0.351 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017910 · form4.xml · derivative · entry 1 Smith Donald R Jr · CIK 0001583749 · VP, CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.245 Underlying: Common Stock · 0.351 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:04 UTC |
Clyde R AndrewDirector · President & CEO
|
GrantDividend Equivalent Units · Derivative | 4.713 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017907 · form4.xml · derivative · entry 3 Clyde R Andrew · CIK 0001582735 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.557 Underlying: Common Stock · 4.713 shares Expires not disclosed F5 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:04 UTC |
Clyde R AndrewDirector · President & CEO
|
GrantDividend Equivalent Units · Derivative | 5.734 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017907 · form4.xml · derivative · entry 2 Clyde R Andrew · CIK 0001582735 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40.686 Underlying: Common Stock · 5.734 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:04 UTC |
Clyde R AndrewDirector · President & CEO
|
GrantDividend Equivalent Units · Derivative | 7.316 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017907 · form4.xml · derivative · entry 1 Clyde R Andrew · CIK 0001582735 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88.53 Underlying: Common Stock · 7.316 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:02 UTC |
Bacon Renee MSVP, Sales & Ops & CMO
|
GrantDividend Equivalent Units · Derivative | 0.446 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017904 · form4.xml · derivative · entry 3 Bacon Renee M · CIK 0001768052 · SVP, Sales & Ops & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.905 Underlying: Common Stock · 0.446 shares Expires not disclosed F5 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F6 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F5 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2023 Omnibus Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F6 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 14, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:02 UTC |
Bacon Renee MSVP, Sales & Ops & CMO
|
GrantDividend Equivalent Units · Derivative | 0.598 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017904 · form4.xml · derivative · entry 2 Bacon Renee M · CIK 0001768052 · SVP, Sales & Ops & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.245 Underlying: Common Stock · 0.598 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F4 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F4 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 8, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:02 UTC |
Bacon Renee MSVP, Sales & Ops & CMO
|
GrantDividend Equivalent Units · Derivative | 0.702 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017904 · form4.xml · derivative · entry 1 Bacon Renee M · CIK 0001768052 · SVP, Sales & Ops & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.491 Underlying: Common Stock · 0.702 shares Expires not disclosed F1 · security: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F2 · derivative.exercise_price: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F3 · shares: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. F2 · derivative.exercise_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F2 · derivative.expiration_date: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. F1 · balance_after: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the 2013 Long-Term Incentive Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs. F3 · balance_after: Reflects the accrual of dividend equivalent units on RSUs granted to the Reporting Person on February 9, 2022. Read SEC document |
| May 21, 2024 Filed May 22, 2024 20:43 UTC |
Smith Donald R JrVP & Corporate Controller
|
Exercise / conversionStock Option · Derivative | 2,000 | $0.00 Strike: $106.72 | $0.00 |
DisclosureSEC source: 0001127602-24-016253 · form4.xml · derivative · entry 5 Smith Donald R Jr · CIK 0001583749 · VP & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2027-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Award granted under the 2013 Long-Term Incentive Plan. F3 · derivative.exercise_date: The option vests in two equal installments, the first half two years after the grant date and the final half three years after the grant date. Read SEC document |
| May 21, 2024 Filed May 22, 2024 20:43 UTC |
Smith Donald R JrVP & Corporate Controller
|
SaleCommon Stock | 854 | $438.75 | $374,692.50 |
DisclosureSEC source: 0001127602-24-016253 · form4.xml · nonDerivative · entry 3 Smith Donald R Jr · CIK 0001583749 · VP & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,099.207 Read SEC document |
| May 21, 2024 Filed May 22, 2024 20:43 UTC |
Smith Donald R JrVP & Corporate Controller
|
Tax withholdingCommon Stock | 1,146 | $443.94 | $508,755.24 |
DisclosureSEC source: 0001127602-24-016253 · form4.xml · nonDerivative · entry 2 Smith Donald R Jr · CIK 0001583749 · VP & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,953.207 F1 · kind: Represents a net exercise of outstanding stock options. These shares were withheld by the Company for payment of the exercise price and applicable taxes, using the closing price on May 21, 2024 of $443.94. Read SEC document |
| May 21, 2024 Filed May 22, 2024 20:43 UTC |
Smith Donald R JrVP & Corporate Controller
|
Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-016253 · form4.xml · nonDerivative · entry 1 Smith Donald R Jr · CIK 0001583749 · VP & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,099.207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.